Family Medicine · Oneill, NE
NPI
1891751277
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
300 N 2nd St, Ste 100
Oneill, NE, 68763
Phone (402) 336-2900
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
241 services
Medicare patients, 2024
60
Average age 81
Drug cost, 2024
$806K
15,464 prescriptions
Company payments, 2025
$14.29
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew G Winkelbauer was code 99233 (hospital e&m - subsequent), 89 times for 29 patients. In total Matthew G Winkelbauer billed 241 services in 14 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 89 | 29 | $85.06 | $7,571 |
| 99232 Hospital E&M - Subsequent | Facility | 71 | 33 | $55.74 | $3,958 |
| 99239 Hospital Discharge Management | Facility | 42 | 32 | $88.19 | $3,704 |
| 99238 Hospital Discharge Management | Facility | 13 | 13 | $57.42 | $746 |
By year: 2022 $20K for 311 services; 2023 $19K for 265 services; 2024 $17K for 241 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew G Winkelbauer prescribed most often to Medicare patients was Levothyroxine Sodium, with 672 prescriptions and refills. In total Matthew G Winkelbauer wrote 15,464 Medicare prescriptions that cost $806K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 672 | 1,306 | 116 | $7,502 |
| Atorvastatin Calcium Generic | 611 | 1,321 | 138 | $4,802 |
| Losartan Potassium Generic | 566 | 1,216 | 125 | $5,431 |
| Omeprazole Generic | 514 | 984 | 107 | $4,813 |
| Potassium Chloride Generic | 443 | 753 | 85 | $12K |
| Pantoprazole Sodium Generic | 435 | 808 | 85 | $6,145 |
| Amlodipine Besylate Generic | 361 | 785 | 86 | $2,408 |
| Furosemide Generic | 334 | 561 | 69 | $1,521 |
| Metformin Hcl Generic | 302 | 629 | 69 | $1,961 |
| Meloxicam Generic | 271 | 516 | 76 | $1,332 |
| Tamsulosin Hcl Generic | 261 | 467 | 54 | $2,794 |
| Metoprolol Tartrate Generic | 255 | 430 | 44 | $1,850 |
| Tramadol Hcl Generic | 248 | 248 | 52 | $2,292 |
| Gabapentin Generic | 247 | 361 | 49 | $4,574 |
| Doxazosin Mesylate Generic | 247 | 437 | 47 | $5,161 |
Brand drugs: 1,360 claims; generic drugs: 14,077 claims; opioid claims: 486.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew G Winkelbauer $14.29 ($14.29 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $14.29.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $14.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.